Cite
HARVARD Citation
McCreary, A. et al. (2016). The novel 5-HT1A receptor agonist, NLX-112 reduces l-DOPA-induced abnormal involuntary movements in rat: A chronic administration study with microdialysis measurements. Neuropharmacology. pp. 651-660. [Online].